This finding further supports the presence of two distinct molecular pathways that underlie formation of atypical meningiomas: either through a de novo pathway as detailed in this study, or due to transformation of benign meningiomas, partially through acquisition of an activating TERT promoter mutation. This evidence concerns the gene TERT and benign meningioma.